Table 2 Demographics and patient characteristics of 365 patients

Age

59.2 (18.5 – 93.0)

59.5 (+/− 13.7)

59.1 (+/− 13.0)

0.853

Missing

0

 M

226 (61.9%)

50 (59.5%)

176 (62.6%)

0.611

 F

139 (38.1%)

34 (40.5%)

105 (37.4%)

 Missing

0

 non-smoker

134 (36.7%)

25 (29.8%)

109 (38.8%)

0.272

 Ex-smoker

111 (30.4%)

32 (38.1%)

79 (28.1%)

 Active smoker

102 (27.9%)

22 (26.2%)

80 (28.5%)

 Missing

18 (4.9%)

5 (8.3%)

13 (4.6%)

 yes

39 (10.7%)

10 (11.9%)

29 (10.3%)

0.794

 no

325 (89.0%)

74 (88.1%)

251 (89.3%)

 missing

1 (0.3%)

0

1 (0.4%)

 10 mm

10 (2.6%)

5 (5.5%)

5 (1.7%)

0.031

 15 mm

279 (72.7%)

67 (73.6%)

212 (72.4%)

 20 mm

6 (1.6%)

2 (2.2%)

4 (1.4%)

 24 mm

16 (4.2%)

7(7.7%)

9 (3.1%)

 28 mm

14 (3.6%)

1(1.1%)

13 (4.4%)

 missing

59 (15.4%)

9 (9.9%)

50 (17.1%)

 yes

233 (63.8%)

49 (58.3%)

184 (65.5%)

0.005

 no

129 (35.3%)

32 (38.1%)

97 (34.5%)

 Missing

3 (0.8%)

3 (3.6%)

 Locking

62 (17.0%)

9 (10.7%)

53 (18.9%)

0.106

 Non-locking

247 (67.7%)

66 (78.6%)

181 (64.4%)

 Missing

56 (15.3%)

9 (10.7%)

47 (16.7%)

 Rescues

76 (20.8%)

18 (21.4%)

58 (20.6%)

0.618

 Non-rescue

234 (64.1%)

57 (67.9%)

177 (63.0%)

 Missing

55 (15.1%)

9 (10.7%)

46 (16.4%)

 adverse^a

179 (49.0%)

45 (53.6%)

135 (48.0%)

0.162

 non-adverse

180 (49.3%)

36 (42.9%)

143 (50.9%)

 missing

6 (1.7%)

3 (3.5%)

3 (1.1%)

 Yes

212 (58.1%)

44 (52.4%)

168 (59.8%)

0.482

 No

149 (40.8%)

39 (46.4%)

110 (39.1%)

 missing

4 (1.1%)

1 (1.2%)

3 (1.1%)

 Osseous +/− cutaneous

212 (58.0%)

40 (47.6%)

172 (61.2%)

0.426

 Soft Tissue

143 (39.2%)

41 (48.8%)

102 (36.3%)

 Local Regional

1 (0.3%)

1 (1.2%)

0 (0.0%)

 Missing

9 (2.5%)

2 (2.4%)

7 (2.5%)

 Follow-up time (Median)

25.2 months

11.1 +/− 27.6 months

30.84 +/− 31.3 months

0.005

 yes

39 (10.7%)

21 (25.0%)

18 (6.4%)

<0.001

 no

324 (88.8%)

63(75.0%)

261 (92.9%)

 missing

2 (0.5%)

2 (0.7%)